CALGB 80405: “A Phase III Trial of Irinotecan/5FU/Leukovorin or Oxaliplatin/5FU/Leukovorin With Bevacizumab or Cetuximab (C225), 0r with the combination of Bevacizumab and Cetuximab for Patients with Untreated Metastatic Adenocarcinoma of the Colon or Rectum” suspended
ECOG E5202: “A Randomized Phase III Study Comparing 5-FU, Leucovorin and Oxaliplatin versus 5FU, Leucovorin, Oxaliplatin and Bevacizumab in Patients with Stage II Colon Cancer at High Risk for Recurrence to Determine Prospectively the Prognostic Value of Molecular Markers”
FER-HO-001: “Measuring Quality Improvement in Breast Cancer Care and Management Throughout Fox Chase Cancer Center Partners’ Hospitals”
GOG 0219: “A Phase III, Randomized Trial of Weekly Cisplatin and Radiation vs. Cisplatin and Tirapazamine and Radiation in Stage IB2, IIB, IIIB, IVA Cervical Carcinoma Limited to the Pelvis”
IRB 07-014: “Phase III Randomized Study of Calendula vs. Biafine to Prevent Radiation-Induced Dermatitis”
IRB 08-011: Familial colorectal Cancer Registry Program at Monmouth Medical Center
PACCT-1/TAILORx: “Program for the Assessment of Clinical Cancer Tests (PACCT-1): Trial Assigning Individualized Options for Treatment”
RTOG 0235 “Positron Emission Tomography Pre- and Post-treatment Assessment for Locally Advanced Non-small Cell Lung Carcinoma”
RTOG 0413/B39 “A Randomized Phase III Study of Conventional Whole Breast Irradiation (WBI) Versus Partial Breast Irradiation (PBI) for Women with Stage 0, I or II Breast Cancer”
RTOG 0522: “A Randomized Phase III Trial of Concurrent Accelerated Radiation and Cisplatin versus Concurrent Accelerated Radiation, Cisplatin, and Cetuximab (C225) [Followed by Surgery for Selected Patients] for Stage III and IV Head and Neck Carcinomas”
RTOG 0617: “A Randomized Phase III Comparison of Standard-Dose (60Gy) versus High-Dose (74Gy) Conformal Radiotherapy with Concurrent and Consolidation Carboplatin/Paclitaxel in Patients with Stage IIIA/IIIB Non-Small Cell Lung Cancer”
RTOG 0614: A Randomized, Phase III, Double-Blind, Placebo-Controlled
Trial of Memantine for Prevention of Cognitive Dysfunction in
Patients Receiving Whole Brain Radiotherapy
RTOG 0615: “A Phase II Study of Concurrent Chemoradiotherapy Using three-Dimensional Conformal Radiotherapy (3D-RT) or Intensity-Modulated Radiation Therapy (IMRT) + Bevacizumab (BV) {NSC 708865; IND 7921} for locally or Regionally Advanced Nasopharyngeal cancer”
RTOG 0822: A Phase II Evaluation of Preoperative Chemoradiotherapy
Utilizing Intensity Modulated Radiation Therapy (IMRT) in Combination
with Capecitabine and Oxaliplatin for Patients with Locally Advanced
Rectal Cancer
RTOG 0436: “a Phase III Teial Evaluating the Addition of Cetuximab to Paclitaxel, Cisplatin and Radiation for Patients with Esophageal Cancer Who Are Treated Without Surgery”
SWOG S0307: “Phase III Trial of Biphosphonates as Adjuvant Therapy for Primary Breast Cancer”
[ medical services index ] [ top ] |
